
Factor Viii Concentrate Powder Suppliers & Bulk Manufacturers
Available Forms: Lyophilized (freeze-dried) powder
Available Strengths: 250 IU, 500 IU, 1000 IU, 2000 IU vials
Reference Brands: Hemofil M, Kogenate FS, Advate(US); Kogenate, Octanate, Lonoctocog alfa(EU)
Category: Blood Disorder
Factor VIII Concentrate powder is available in Lyophilized (freeze-dried) powder and strengths such as 250 IU, 500 IU, 1000 IU, 2000 IU vials. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Factor VIII Concentrate powder is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Factor VIII Concentrate powder can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Factor VIII concentrates are approved in both the US and EU, supported by comprehensive dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA regulates these products, while the EMA oversees approval in the EU. Dossiers include clinical trial data, stability, and pharmacovigilance information. These concentrates are essential for hemophilia A management, used to prevent and treat bleeding episodes. Both regions require rigorous evaluation before market authorization. For detailed regulatory insights, licensing requirements, and approved dossiers for Factor VIII concentrates, visit Pharmatradz. Stay updated on global regulatory standards and market access pathways for hemophilia treatments.
Frequently Asked Questions
Related Products
Anti-Inhibitor Coagulant Complex (Aicc) Lyophilized Powder
Strength:
500 units, 1000 units, and 2500 units
Form: Lyophilized Powder (Reconstituted for IV infusion)
Reference Brands: FEIBA(US)
View DetailsProthrombin Complex Concentrate (Pcc) Injection
Strength:
250 IU to 300 IU
Form: Injection
Reference Brands: Kcentra (4-factor PCC), Bebulin VH (3-factor PCC)(US)
View DetailsLeucovorin Tablets/Capsule
Strength:
15 mg, 50 mg
Form: Tablet/Capsules
Reference Brands: Folvite(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers